← All trials
NCT04618523
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 26, 2020
- Primary completion
- Jul 30, 2021
- Completion date
- Aug 30, 2021
- First posted
- Nov 6, 2020
- Last posted
- Nov 9, 2020
- Enrollment
- 1056
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Government of the Democratic Republic of the CongoLead sponsor
- Government of the Democratic Republic of the CongoReponsible party - principal investigator
- World Health OrganizationCollaborator
- University of KinshasaCollaborator
- Government of CongoCollaborator
- University of KinshasaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.